Our Mission
At Emergent, we develop, manufacture, and deliver protections against public health threats through a pipeline of innovative vaccines and therapeutics worldwide. For 25 years, we’ve been at work defending people from things we hope will never happen—so that we’re prepared, just in case they ever do. We do what we do because we see the opportunity to create a better, more secure world. One where preparedness empowers protection from the threats we face. And peace of mind prevails. We:
- Step up to fight critical, even deadly, health threats
- Maintain a critical role in the ongoing opioid crisis
- Secure the “health confidence” that keeps us all prepared
Our History
Emergent opened for business, partnering with the U.S. government to supply BioThrax (Anthrax Vaccine Absorbed) for military members.
Emergent BioSolutions common stock begins trading on the New York Stock Exchange ($EBS).
Received funding for CYFENDUS™ (Anthrax Vaccine Absorbed, Adjuvanted) from the Biomedical Advanced Research and Development Authority (BARDA) and National Institute of Allergy and Infectious Diseases (NIAID).
Acquired rights to auto-injector technology, growing our devices business.
Acquired NARCAN® Nasal Spray (naloxone HCl).
Our Culture and Values
Our culture is informed by our values and commitment to protecting and enhancing lives. For all the people touched by our work, we operate with an unwavering commitment to honesty, integrity, and quality.